Food and Drug Administration has approved Sublocade, the first once-monthly injectable buprenorphine product for the treatment of moderate-to-severe opioid use
stay healthy…
Food and Drug Administration has approved Sublocade, the first once-monthly injectable buprenorphine product for the treatment of moderate-to-severe opioid use